Fatal Incidents Trigger Nationwide Cough Syrup Inspections by CDSCO

Date:

Share post:

Fatal Incidents Trigger Nationwide Cough Syrup Inspections by CDSCO

PharmaGenDRx News Bureau,8th October, 2025

06:00 PM IST

Following the recent reports of fatalities linked with the cough syrups in Rajasthan and Madhya Pradesh, the Central Drugs Standard Control Organisation (CDSCO) has launched a nationwide inspection, risk-based drive across nineteen manufacturing units in six states.This decision was announced as a result of an intrinsic review meeting chaired by the Union Health Secretary, directing all states and Union Territories to ensure strict compliance with Revised Schedule M (Good Manufacturing Practices) and to increase caution on the quality and rationalised use of cough syrups. During the inspection, preliminary tests detected the presence of Diethylene Glycol (DEG), a toxic contaminant, in the syrups. Reaffirming its zero-tolerance policy on substandard, contaminated and inferior drugs, the Health Ministry aims at uncovering gaps, bolstering oversights and safeguarding the public with this initiative to ensure to strengthen faith of the public in Indian Pharmaceutical Manufacturing Standards.

By Arundhuti Chatterjee and Sharon Bose

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Dabur India Plant Under US FDA Scanner Over Contamination Concerns

The United States Food and Drug Administration (US FDA) has flagged serious concerns at Dabur India's manufacturing facility...

FDA Approves Wockhardt’s Novel Antibiotic ZAYNICH™️ for cUTI

Wockhardt Limited  announced that the U.S. Food and Drug Administration (FDA) has approved ZAYNICH™ (cefepimeand zidebactam), a novel intravenous antibiotic...

Relief for Patients: NPPA Fixes Ceiling Prices for 30 Essential Medicines

The National Pharmaceutical Pricing Authority (NPPA) has notified ceiling prices for 30 essential fixed-dose combination medicines under the...

FDA Draft Guidance Aims to Reduce Animal Testing for Cancer Drugs

The U.S. Food and Drug Administration (FDA) issued a new draft guidance aimed at reducing unnecessary animal testing...